Digestive System Carcinoma — Trials

Digestive System Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

7,540 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 2,123
Recruiting: 1,216
Ph III recruiting: 129
Growth YoY: +14.1%
Industry share: 23%
Top sponsor: National Cancer Institute (NCI)
Termination share: 34.2%

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (884)

clinicaltrialsPublishedShowing 2,951–2,978 of 2,978 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT00635323	Safety And Efficacy Of Irinotecan Plus Capecitabine As First-Line Treatment In Asian Subjects With Hepatocellular Carcinoma	completed	Phase 2	73	PfizerINDUSTRY	4	Apr 7, 2008	clinicaltrials
NCT00051987	Phase 2b Study of VELCADE Alone and VELCADE Plus Irinotecan in Patients With Relapsed or Refractory Colorectal Carcinoma	completed	Phase 2	175	Millennium Pharmaceuticals, Inc.INDUSTRY	1	Feb 11, 2008	clinicaltrials